Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Download All
Gain expert pharmacist perspective on newly approved and emerging therapies for relapsed/refractory multiple myeloma with a webcast of a live webinar plus downloadable slidesets.
Sagar Lonial, MD
Kathryn Maples, PharmD, BCOP

Downloadable Slidesets

Download these slides from a live webinar for the most recent data on the optimal treatment options for patients with relapsed or refractory myeloma, including information on how to incorporate these agents into your current clinical practice.

Sagar Lonial, MD Kathryn Maples, PharmD, BCOP Released: May 4, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie Inc.
Bristol-Myers Squibb
Karyopharm Therapeutics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue